Hematology/Coagulation
News on hematology and coagulation testing systems and applications.
Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform
Caris and ConcertAI will combine their multiomic and multimodal databases and AI technology to create a unified platform for use in oncology and hematology.
The molecular diagnostics company seeks to automate its customers' pipelines with AI and diversify beyond hematology.
Adaptive Biotechnologies Q1 Revenues up 84 Percent, Beat Analyst Estimates
The company attributed its $38.4 million in quarterly revenues to strong progress in both the sequencing and development services arms of its business.
Bio-Rad Q4 Revenues Down 1 Percent, Beat Estimates
The company's full-year revenues rose 6 percent and were slightly higher than the consensus Wall Street estimate.
FDA Approves Progenika MDx Assay for Blood Compatibility
The ID Core XT is the second molecular assay approved by the FDA for use in transfusion medicine and the first to report genotypes as final results.